Patients with lung cancer face an approximate 3% risk of venous thromboembolism over a 2-year period.
Suggests VTE vigilance after lung cancer resection; leaves open optimal prophylaxis strategies in prospective trials.
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are common complications in cancer. Patients with lung cancer have a risk of venous thromboembolism (VTE) of around 3% over 2 years.
No takes yet. Share an insight, caveat, or question.
Styliani Maria Kolokotroni (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: